Abiopharma

Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026

Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2026 Outlook

ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025

WAGNER CHARLES F JR 🟡 adjusted position in 9.5K shares (1 derivative) of VERTEX PHARMACEUTICALS INC / MA (VRTX) at $461.00 ($8.0M) Transaction Date: Jan 06, 2026 | Filing ID: 000002

Schmid John P. 🟢 acquired 9.5K shares (2 derivative) of ANAPTYSBIO, INC (ANAB) at $43.91 Transaction Date: Jan 06, 2026 | Filing ID: 000001

New Form SCHEDULE 13G/A - PLIANT THERAPEUTICS, INC. Filed: 2026-01-08 AccNo: 0000895421-26-000001 Size: 8 KB

Issa Mohamed Khairie 🔴 sold 19.1K shares of INCYTE CORP (INCY) at $109.07 ($2.1M) Transaction Date: Jan 06, 2026 | Filing ID: 000002

New Form S-8 - LISATA THERAPEUTICS, INC. Filed: 2026-01-08 AccNo: 0000320017-26-000003 Size: 108 KB

New Form S-3 - Flora Growth Corp. Filed: 2026-01-08 AccNo: 0001062993-26-000127 Size: 494 KB

(99% Neutral) PHATHOM PHARMACEUTICALS, INC. (PHAT) Announces Business Combination

Director Bassler Bonnie L 🟡 adjusted position in 1.5K shares (1 derivative) of REGENERON PHARMACEUTICALS, INC. (REGN) at $800.00 ($2.3M) Transaction Date: Jan 07, 2026 | Filing ID: 000008

Ware J. Anthony 🟢 acquired 9.5K shares (2 derivative) of ANAPTYSBIO, INC (ANAB) at $43.91 Transaction Date: Jan 06, 2026 | Filing ID: 000001

(90% Positive) PACIRA BIOSCIENCES, INC. (PCRX) Provides Update on leader for sustainable

Orwin John A 🟢 acquired 14.2K shares (2 derivative) of ANAPTYSBIO, INC (ANAB) at $43.91 Transaction Date: Jan 06, 2026 | Filing ID: 000001

New Form S-3 - Avalo Therapeutics, Inc. Filed: 2026-01-08 AccNo: 0001104659-26-002118 Size: 1 MB